Marin Vulic Email Address
@serestherapeutics.com
Senior Principal Scientist and Microbiologist
Seres Therapeutics, Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome, where the natural state of bacterial diversity and function is imbalanced. A Phase 2 study of Seres' program SER-109 has been completed in multiply recurrent Clostridium difficile infection. Seres' clinical candidate, SER-287, is being evaluated in a Phase 1b study in patients with mild-to-moderate ulcerative colitis (UC). Seres is also developing SER-262, the first ever synthetic microbiome therapeutic candidate, in a Phase 1b study in patients with primary CDI.
Expertise in anaerobic microbiology, gut microbiota, bacterial molecular genetics and physiology, antibiotic resistance and tolerance, drug discovery
Other people working at Seres Therapeutics:
How does this work?
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you're looking to find the email of Marin Vulic at Seres Therapeutics then you've come to the right place.
Wondering if it's marin@serestherapeutics.com, marin.vulic@serestherapeutics.com, vulic@serestherapeutics.com, or mvulic@serestherapeutics.com? We have the answers for you.